


AdBio partners appoints Geoffroy de Ribains as Managing Partner

Agomab Reports Positive Phase 1 Results with AGMB-129, a GI-restricted ALK5 Inhibitor for Fibrostenosing Crohn’s Disease

Ribonexus appoints Steven Powell as CEO

Univercells raises € 44 million in first close of its Series D
